# Balto Pharmaceuticals, Inc. — Form D

Balto Pharmaceuticals, Inc. of SOUTH PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-14. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-09-14
- Form: D
- Accession: 0001993350-23-000001
- Industry: Pharmaceuticals
- Exemptions: 04, 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Investors: 2
- Date of first sale: 2023-08-22
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-492095

## Issuer

- Name: Balto Pharmaceuticals, Inc.
- CIK: 0001993350
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 99 PASADENA AVENUE, SOUTH PASADENA, CA, 91030
- Phone: 626-678-3368

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Chanxing Wilson Xu | Executive Officer | South Pasadena, CA |

## More

- [CIK 1993350 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1993350&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001993350-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.